Carbiotix joins the Global Prebiotic Association (GPA)
Carbiotix (publ) ("Carbiotix") announces today that the company has been accepted as an Associate Member of the Global Prebiotic Association (GPA). This membership will allow Carbiotix to join a limited group of companies promoting the growth of prebiotics and demonstrates Carbiotix potential impact and recognition in the global prebiotics industry.
The GPA is an association comprised of ingredient manufacturers, brand holders and retailers, focused on raising awareness of and support for the prebiotics category. The mission of the GPA is to increase public awareness about the production, quality and science of prebiotic products, expand manufacturer understanding of the solid science supporting both well-known and newfound benefits, and create needed transparency about product quality (https://prebioticassociation.org/).
Kristofer Cook, CEO for Carbiotix, comments
“Joining the GPA will allow Carbiotix to be recognised as a key player in the global prebiotics industry and influence the development of the industry going forward from a scientific and market perspective. We look forward to taking an active role in growing the global prebiotics industry and helping the market to understand the potential benefits of prebiotics. This will in turn assist us to position our corn fiber extract containing AXOS as a leading prebiotic alternative.”
Len Monheit, Executive Director for GPA, comments
“We are happy to have Carbiotix join as an Associate Level Member of the GPA and look forward to interacting with the company alongside our other members. Carbiotix has the potential to make a positive impact on the development of the prebiotics industry and thus I welcome its involvement in GPA related activities.”
This information is information that Carbiotix AB is obliged to make public according to the EU Market Abuse Regulation (MAR). The information was made publicly available by the company’s contact person set out below on 10 March 2020.
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios described in this press release.
For further information:
Kristofer Cook, CEO
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.